Viela Bio
-
Newtown Square’s ArriVent Has Stock Sale for Cancer Drug
A Newtown Square biopharmaceutical company, ArriVent, has raised $110 million in a private stock sale to bring cancer medicines approved in China to the U.S.…
Founding Partners
Advertisement
Affiliate Partners
Chamber Partners
